GLP-1 activation slows gastric emptying, reduces appetite signaling from the gut to the brain, and increases the sensation of fullness after meals
Un paciente con diabetes que tambin intenta dejar de fumar podra razonablemente elegir un GLP-1 en lugar de otro medicamento para reducir la glucosa, no porque est aprobado para dejar el tabaco, sino porque podra ayudarle a lograrlo, un beneficio que otros frmacos para la diabetes no ofrecen
No metabolic effects on breast-fed newborn/infant are anticipated as insulin glargine is digested into amino acids in the gastrointestinal tract
Compound Code: Our medication creates opportunity Compound helps you seize it
Similar findings have been made in evaluations of patients with PD [28,29,30]
In the biodistribution study, more drug accumulated at tumor sites in APAP@PEG/HMnO 2 -treated mice